Health Revenue Assurance Holdings, Inc. (HRAA)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Health Revenue Assurance Holdings, Inc. (HRAA) with AI Score 44/100 (Weak). Health Revenue Assurance Holdings, Inc. provides revenue cycle services to healthcare providers in the United States, including data analysis, coding, and compliance. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 17, 2026Health Revenue Assurance Holdings, Inc. (HRAA) Healthcare & Pipeline Overview
Health Revenue Assurance Holdings, Inc. offers revenue cycle management solutions for healthcare providers, focusing on data analysis, coding, and compliance. Operating in the competitive healthcare sector, the company caters to providers seeking to optimize revenue streams and navigate complex regulatory landscapes, but faces challenges given its negative profitability.
Investment Thesis
Investing in Health Revenue Assurance Holdings, Inc. presents a high-risk, high-reward scenario. The company operates in the growing healthcare revenue cycle management market, but its negative profit margin of -6.9% and a negative P/E ratio of -1.40 indicate significant financial challenges. A potential turnaround hinges on the company's ability to improve operational efficiency and capitalize on growth opportunities within the healthcare sector. The negative beta of -2.34 suggests the stock moves inversely to the market, but this may reflect its financial instability rather than true diversification benefits. Growth catalysts include expanding service offerings and penetrating new geographic markets. However, investors should carefully consider the risks associated with the company's financial performance and OTC market listing.
Based on FMP financials and quantitative analysis
Key Highlights
- Negative P/E ratio of -1.40 indicates the company is currently unprofitable.
- Gross Margin of 13.4% suggests potential for improvement in operational efficiency.
- Negative Profit Margin of -6.9% highlights financial challenges.
- Beta of -2.34 indicates the stock's price is inversely correlated with the market.
- The company operates in the healthcare revenue cycle management market, which is expected to grow.
Competitors & Peers
Strengths
- Specialized expertise in healthcare revenue cycle management.
- Comprehensive suite of services.
- Established presence in the US market.
Weaknesses
- Negative profit margin.
- Small market capitalization.
- OTC market listing.
Catalysts
- Potential for strategic partnerships with healthcare systems to drive revenue growth.
- Increasing demand for revenue cycle management services due to evolving regulations.
- Expansion into new geographic markets to broaden client base.
Risks
- Intense competition in the healthcare RCM market could limit growth.
- Negative profit margin and financial instability may hinder operations.
- OTC market listing increases volatility and reduces liquidity.
- Changes in healthcare regulations could impact the demand for services.
Growth Opportunities
- Expansion into Telehealth Billing: The increasing adoption of telehealth services presents a significant growth opportunity for Health Revenue Assurance Holdings, Inc. As telehealth becomes more prevalent, healthcare providers require specialized billing and coding expertise to navigate the unique challenges of remote patient care. By developing expertise in telehealth billing, the company can tap into a rapidly expanding market segment. The telehealth market is projected to reach $55 billion by 2027, offering a substantial revenue opportunity for companies providing related services.
- Strategic Partnerships with Healthcare Systems: Forming strategic partnerships with large healthcare systems can provide Health Revenue Assurance Holdings, Inc. with access to a broader client base and recurring revenue streams. By integrating its services into the workflows of these systems, the company can establish long-term relationships and secure a steady flow of business. This approach can also enhance the company's credibility and reputation within the industry. The healthcare systems market represents a multi-billion dollar opportunity, with potential for significant revenue growth through strategic alliances.
- Development of Proprietary Technology Solutions: Investing in the development of proprietary technology solutions can differentiate Health Revenue Assurance Holdings, Inc. from its competitors and enhance its service offerings. By creating innovative tools for revenue cycle management, the company can improve efficiency, accuracy, and compliance for its clients. This can also lead to increased customer satisfaction and retention. The market for healthcare technology solutions is growing rapidly, driven by the need for improved efficiency and data analytics.
- Geographic Expansion into Underserved Markets: Expanding its geographic footprint into underserved markets can provide Health Revenue Assurance Holdings, Inc. with access to new clients and revenue streams. By targeting regions with limited access to revenue cycle management services, the company can establish a strong presence and capture market share. This approach requires careful market research and strategic planning, but can yield significant long-term benefits. The underserved markets represent a substantial opportunity for companies seeking to expand their reach and impact.
- Focus on Value-Based Care Reimbursement Models: As the healthcare industry shifts towards value-based care reimbursement models, Health Revenue Assurance Holdings, Inc. can capitalize on this trend by developing expertise in these new payment systems. By helping healthcare providers navigate the complexities of value-based care, the company can position itself as a valuable partner and secure a competitive advantage. The transition to value-based care is expected to accelerate in the coming years, creating a growing demand for related services.
Opportunities
- Expansion into telehealth billing.
- Strategic partnerships with healthcare systems.
- Development of proprietary technology solutions.
Threats
- Intense competition in the healthcare RCM market.
- Evolving regulations and payer requirements.
- Potential for cybersecurity breaches and data privacy violations.
Competitive Advantages
- Specialized expertise in healthcare revenue cycle management.
- Established relationships with healthcare providers.
- Comprehensive suite of services covering various aspects of the revenue cycle.
About HRAA
Health Revenue Assurance Holdings, Inc., founded in 2001 and headquartered in New York City, specializes in providing revenue cycle services to healthcare providers across the United States. The company's core offerings encompass a range of solutions designed to optimize revenue streams and ensure regulatory compliance for its clients. These services include revenue cycle data analysis, contract management, outsourced coding services, and comprehensive billing, coding, and compliance audits. Additionally, Health Revenue Assurance Holdings, Inc. offers coding education, coding consulting, physician coding, and ICD-10 education and transition services. By focusing on these specialized services, the company aims to assist healthcare providers in navigating the complexities of revenue cycle management, allowing them to focus on patient care while ensuring financial stability. The company's suite of services is designed to address the evolving needs of the healthcare industry, particularly in the areas of regulatory compliance and revenue optimization. Health Revenue Assurance Holdings, Inc. positions itself as a partner to healthcare providers, offering expertise and support in managing the financial aspects of their operations.
What They Do
- Provides revenue cycle data analysis to healthcare providers.
- Offers contract management services to optimize revenue streams.
- Provides outsourced coding services to ensure accurate billing.
- Conducts billing, coding, and compliance audits.
- Offers coding education and consulting services.
- Provides physician coding services.
- Offers ICD-10 education and transition services.
Business Model
- Provides revenue cycle management services to healthcare providers.
- Generates revenue through fees for services rendered.
- Focuses on improving the financial performance of its clients.
Industry Context
Health Revenue Assurance Holdings, Inc. operates within the healthcare revenue cycle management (RCM) market. This market is characterized by increasing complexity due to evolving regulations, payer requirements, and technological advancements. Healthcare providers are increasingly seeking external expertise to optimize their revenue cycle processes, driving demand for RCM services. The market is competitive, with a mix of large established players and smaller niche providers. Health Revenue Assurance Holdings, Inc. competes with companies offering similar services, and must differentiate itself through specialized expertise, technology, or customer service. The company's success depends on its ability to adapt to changing industry dynamics and provide value to its clients.
Key Customers
- Hospitals and healthcare systems.
- Physician practices and clinics.
- Other healthcare providers.
Financials
Chart & Info
Health Revenue Assurance Holdings, Inc. (HRAA) stock price: Price data unavailable
Latest News
No recent news available for HRAA.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for HRAA.
Price Targets
Wall Street price target analysis for HRAA.
MoonshotScore
What does this score mean?
The MoonshotScore rates HRAA's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
HRAA OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Health Revenue Assurance Holdings, Inc. may not meet the minimum financial standards required for higher tiers like OTCQB or OTCQX. Companies in this tier may have limited financial disclosure and may not be subject to the same regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. This tier is often associated with higher risk and greater potential for volatility due to the lack of stringent listing requirements.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure.
- Higher potential for fraud and manipulation.
- Lower liquidity and wider bid-ask spreads.
- Greater price volatility.
- Potential for delisting or suspension of trading.
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's legal and regulatory compliance.
- Review the company's risk factors and potential liabilities.
- Consult with a qualified financial advisor.
- Understand the risks associated with investing in OTC stocks.
- Years in operation (founded in 2001).
- Specific business focus (healthcare revenue cycle management).
- Headquarters in New York City.
Common Questions About HRAA (Healthcare)
What does Health Revenue Assurance Holdings, Inc. do?
Health Revenue Assurance Holdings, Inc. specializes in providing revenue cycle management services to healthcare providers in the United States. This includes a range of services such as revenue cycle data analysis, contract management, outsourced coding, billing and compliance audits, and coding education. Their aim is to optimize revenue streams and ensure regulatory compliance for healthcare providers, allowing them to focus on patient care while maintaining financial stability. The company operates in a competitive market, offering expertise to navigate the complexities of healthcare finance.
What do analysts say about HRAA stock?
As of 2026-03-17, there is no readily available analyst coverage or consensus for Health Revenue Assurance Holdings, Inc. This is likely due to its OTC listing and small market capitalization. Key valuation metrics such as P/E ratio (-1.40) and profit margin (-6.9%) suggest the company is currently facing financial challenges. Investors should conduct their own thorough research and consider the risks associated with investing in a thinly traded OTC stock before making any investment decisions.
What are the main risks for HRAA?
The main risks for Health Revenue Assurance Holdings, Inc. include its negative profit margin, which indicates financial instability. The company also faces intense competition in the healthcare revenue cycle management market. Its OTC market listing increases volatility and reduces liquidity, making it difficult to buy or sell shares. Additionally, changes in healthcare regulations could impact the demand for its services. Investors should carefully consider these risks before investing.
What are the key factors to evaluate for HRAA?
Health Revenue Assurance Holdings, Inc. (HRAA) currently holds an AI score of 44/100, indicating low score. Key strength: Specialized expertise in healthcare revenue cycle management. Primary risk to monitor: Intense competition in the healthcare RCM market could limit growth. This is not financial advice.
How frequently does HRAA data refresh on this page?
HRAA prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven HRAA's recent stock price performance?
Recent price movement in Health Revenue Assurance Holdings, Inc. (HRAA) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Specialized expertise in healthcare revenue cycle management. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider HRAA overvalued or undervalued right now?
Determining whether Health Revenue Assurance Holdings, Inc. (HRAA) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying HRAA?
Before investing in Health Revenue Assurance Holdings, Inc. (HRAA), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- OTC market data may be limited and subject to inaccuracies.
- AI analysis is pending and may provide additional insights.